We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LANDP:NASDAQGladstone Land Corporation - 6.00% Series C Cumulative Redeemable Preferred Stock Analysis

Data as of 2026-08-24 - not real-time

$20.68

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

At $20.68, Gladstone Land Corporation shows a bullish moving-average alignment, with shorter averages sitting above longer ones. With RSI at 38.7 the momentum picture is approaching oversold, alongside a bearish MACD signal. The recent range runs from support at $20.59 up to resistance at $21.50.
Revenue is growing at 4.2% on a -7.3% profit margin. The 7.25% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 11.2%, a beta of 0.07 and a maximum drawdown of 7.4%, position sizing matters here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.

Top Market Events

MCLEAN, VA / ACCESS Newswire / July 14, 2026 / Gladstone Land Corporation Nasdaq:LAND "Gladstone Land" or the "Company"...Get the latest breaking news, sports, entertainment and obituaries in Brockton, MA from Enterprise News.MCLEAN, VA / ACCESS Newswire / July 15, 2026 / Gladstone Land Corporation Nasdaq:LAND "Gladstone Land" or the "Company"...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 20.01
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 20.01
  • MACD momentum is negative

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Negative profit margin of -7.3%
  • Negative return on equity of -1.0%
  • Dividend yield of 7.25%

Key Metrics & Analysis

Financial Health

Revenue Growth4.20%
Profit Margin-7.30%
ROE-0.96%
ROA1.11%
Debt/Equity72.31
P/B Ratio1.3
Op. Cash Flow$27.8M
Free Cash Flow$44.3M
Industry P/E32.7

Technical Analysis

TrendBullish
RSI38.7
Support$20.59
Resistance$21.50
MA 20$21.15
MA 50$20.80
MA 200$20.01
MACDBearish
VolumeStable
Fear & Greed Index94.41

Valuation

GradeFair
TypeValue
Dividend Yield7.25%

Risk Assessment

Beta0.07
Volatility11.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.